Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Geynisman

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Targeted Therapy for Metastatic Urothelial Cancer: A Work in ProgressElizabeth R Plimack, Daniel M Geynisman
European Urology|May 11, 2021
Systemic Therapy for Advanced Non-clear-Cell Renal Cell Carcinoma: Slow but Definite ProgressDaniel M Geynisman, Elizabeth R Plimack
Journal of Oncology Practice|May 11, 2017
Bending the Curve of Advanced Urothelial CarcinomaDaniel M Geynisman, Elizabeth R Plimack
Urology Case Reports|June 30, 2017
Resolution of a Debilitating Paraneoplastic Parkinson-like Neurological Syndrome Following Tyrosine Inhibitor Therapy and Consolidative Nephrectomy in a Patient with Advanced Clear Cell Renal Cell CarcinomaNaveed Ali, Alexander Kutikov, Daniel M Geynisman
Discovery Medicine|August 1, 2012
Toward personalized treatment of advanced biliary tract cancersDaniel M Geynisman, Daniel V T Catenacci
Cancers|October 14, 2022
Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell CarcinomaKevin K Zarrabi, Oladimeji Lanade, Daniel M Geynisman
Translational Andrology and Urology|April 9, 2024
Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analysesKevin K Zarrabi, Benjamin Miron, Daniel M Geynisman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factorAhad A Sadiq, Daniel M Geynisman, Ravi Salgia
European Urology|May 31, 2016
Second-generation Androgen Receptor-targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?Daniel M Geynisman, Elizabeth R Plimack, Matthew Zibelman
The Journal of Urology|September 5, 2025
Editorial CommentGregory Hemenway, Elizabeth R Plimack, Daniel M Geynisman
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Targeted Therapy for Metastatic Urothelial Cancer: A Work in ProgressElizabeth R Plimack, Daniel M Geynisman
European Urology|May 11, 2021
Systemic Therapy for Advanced Non-clear-Cell Renal Cell Carcinoma: Slow but Definite ProgressDaniel M Geynisman, Elizabeth R Plimack
Journal of Oncology Practice|May 11, 2017
Bending the Curve of Advanced Urothelial CarcinomaDaniel M Geynisman, Elizabeth R Plimack
Urology Case Reports|June 30, 2017
Resolution of a Debilitating Paraneoplastic Parkinson-like Neurological Syndrome Following Tyrosine Inhibitor Therapy and Consolidative Nephrectomy in a Patient with Advanced Clear Cell Renal Cell CarcinomaNaveed Ali, Alexander Kutikov, Daniel M Geynisman
Discovery Medicine|August 1, 2012
Toward personalized treatment of advanced biliary tract cancersDaniel M Geynisman, Daniel V T Catenacci
Cancers|October 14, 2022
Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell CarcinomaKevin K Zarrabi, Oladimeji Lanade, Daniel M Geynisman
Translational Andrology and Urology|April 9, 2024
Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analysesKevin K Zarrabi, Benjamin Miron, Daniel M Geynisman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factorAhad A Sadiq, Daniel M Geynisman, Ravi Salgia
European Urology|May 31, 2016
Second-generation Androgen Receptor-targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?Daniel M Geynisman, Elizabeth R Plimack, Matthew Zibelman
The Journal of Urology|September 5, 2025
Editorial CommentGregory Hemenway, Elizabeth R Plimack, Daniel M Geynisman
Pageof 19